Brussels, Belgium

Daniele Godelaine



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2004-2011

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniele Godelaine

Introduction

Daniele Godelaine is a prominent inventor based in Brussels, Belgium. He has made significant contributions to the field of cancer research, particularly through his innovative patents. With a total of five patents to his name, Godelaine's work focuses on tumor-associated nucleic acids and their applications in diagnosis and treatment.

Latest Patents

One of Godelaine's latest patents is titled "LAGE-1 tumor associated nucleic acids." This invention describes the LAGE-1 tumor-associated gene, including its fragments, allelic variants, and splice variants. It also encompasses polypeptides and fragments encoded by such genes, along with antibodies related to them. The patent provides methods and products for diagnosing and treating conditions characterized by the expression of a LAGE-1 gene product.

Another significant patent is "MAGE-C2 antigenic peptides and uses thereof." This invention relates to isolated peptides derived from MAGE-C2, as well as nucleic acid molecules that encode these peptides. It includes expression vectors comprising the nucleic acid molecules and host cells transformed or transfected with them. The patent also discusses tetramers comprising the peptides, HLA molecules, β-microglobulin, and binding partners. Furthermore, it outlines methods for utilizing these peptides and nucleic acid molecules in therapeutic applications.

Career Highlights

Daniele Godelaine is affiliated with the Ludwig Institute for Cancer Research Limited, where he continues to advance his research in cancer-related innovations. His work has garnered attention for its potential impact on cancer diagnosis and treatment.

Collaborations

Godelaine collaborates with notable colleagues, including Thierry R Boon-Falleur and Sophie Lucas. Their combined expertise contributes to the advancement of cancer research and the development of innovative therapeutic strategies.

Conclusion

Daniele Godelaine's contributions to cancer research through his patents highlight his role as an influential inventor in the field. His work not only enhances our understanding of tumor-associated genes but also paves the way for new diagnostic and therapeutic approaches.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…